Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF + CHOP-R in Untreated DLBCL
NCT00455897Phase 2Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2006
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in diffuse large B-cell lymphoma (DLBCL), sponsored by Massachusetts General Hospital. Started Dec 2006; status: terminated.
02
Drugs
sargramostim
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00455897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455897.